OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics® announced today that it is currently in the very late planning stages of expanding within the 44,000 square-foot manufacturing facility located in Oklahoma City, Oklahoma. Cytovance Biologics® currently specializes in the execution of clinical production of antibody and recombinant protein products derived from cell culture at scales up to 500L (w/v) from batch, fed-batch and perfusion processes.
